Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,572 | 57,809 | 82,421 | 26,261 | 44,360 |
| Marketable Securities | 87,582 | 79,468 | 50,374 | 20,805 | 9,100 |
| Receivables | 20,790 | 16,231 | 17,867 | 25,721 | 16,759 |
| Inventories | 21,323 | 19,570 | 14,927 | 9,927 | 11,301 |
| Other current assets | 2,695 | 0 | 1,823 | 0 | 1,877 |
| TOTAL | $172,962 | $175,914 | $167,412 | $84,514 | $83,397 |
| Non-Current Assets | |||||
| PPE Net | 38,362 | 26,210 | 19,420 | 19,580 | 20,419 |
| Intangibles | 841 | 989 | 1,137 | 1,284 | 1,432 |
| Other Non-Current Assets | 11,369 | 11,477 | 7,044 | 6,214 | 6,225 |
| TOTAL | $50,572 | $38,676 | $27,601 | $27,078 | $28,076 |
| Total Assets | $223,534 | $214,590 | $195,013 | $111,592 | $111,473 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 3,431 | N/A |
| Accounts payable and accrued liabilities | 23,071 | 21,241 | 15,421 | 10,333 | 12,249 |
| Accrued Expenses | 12,716 | 13,074 | 8,609 | 7,396 | 7,493 |
| Other current liabilities | 5,250 | 3,614 | 3,245 | 3,793 | 2,732 |
| TOTAL | $44,130 | $40,670 | $29,145 | $26,809 | $24,316 |
| Non-Current Liabilities | |||||
| Long Term Debt | 71,297 | 70,743 | 70,189 | 66,210 | 69,145 |
| Other Non-Current Liabilities | 13,909 | 9,220 | 5,502 | 5,570 | 5,849 |
| TOTAL | $85,206 | $79,963 | $75,691 | $71,780 | $74,994 |
| Total Liabilities | $129,336 | $120,633 | $104,836 | $98,589 | $99,310 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,086 | 71,721 | 71,071 | 61,890 | 60,776 |
| Common Shares | 7 | 7 | 7 | 6 | 6 |
| Retained earnings | -532,877 | -529,153 | -525,925 | -521,241 | -514,233 |
| Other shareholders' equity | 252 | 152 | 100 | 61 | 96 |
| TOTAL | $94,198 | $93,957 | $90,177 | $13,003 | $12,163 |
| Total Liabilities And Equity | $223,534 | $214,590 | $195,013 | $111,592 | $111,473 |